Cargando…
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist
BACKGROUND: The importance of tapering is increasingly recognised when discontinuing antidepressant medication. However, no previous studies have examined the reporting of antidepressant tapering methods in published studies. AIM: The aim of this study was to assess the completeness of reporting of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600051/ https://www.ncbi.nlm.nih.gov/pubmed/37269440 http://dx.doi.org/10.1007/s11096-023-01602-z |
_version_ | 1785125903644229632 |
---|---|
author | McGoldrick, Amy Byrne, Helen Cadogan, Cathal |
author_facet | McGoldrick, Amy Byrne, Helen Cadogan, Cathal |
author_sort | McGoldrick, Amy |
collection | PubMed |
description | BACKGROUND: The importance of tapering is increasingly recognised when discontinuing antidepressant medication. However, no previous studies have examined the reporting of antidepressant tapering methods in published studies. AIM: The aim of this study was to assess the completeness of reporting of antidepressant tapering methods in a published systematic review using the Template for Intervention Description and Replication (TIDieR) checklist. METHOD: A secondary analysis was conducted of studies included in a Cochrane systematic review that examined the effectiveness of approaches for discontinuing long-term antidepressant use. The completeness of reporting of antidepressant tapering methods in included studies was independently assessed by two researchers using the 12 items from the TIDieR checklist. RESULTS: Twenty-two studies were included in the analysis. None of the study reports described all checklists items. No study clearly reported what materials had been provided (item 3) or whether tailoring had occurred (item 9). With the exception of providing a name for the intervention or study procedures (item 1), only a minority of studies clearly reported on any of the remaining checklist items. CONCLUSION: The findings highlight a lack of detailed reporting of antidepressant tapering methods in published trials to date. This needs to be addressed as poor reporting could hinder replication and adaptation of existing interventions, as well as the potential for successful translation of effective tapering interventions into clinical practice. |
format | Online Article Text |
id | pubmed-10600051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106000512023-10-27 An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist McGoldrick, Amy Byrne, Helen Cadogan, Cathal Int J Clin Pharm Research Article BACKGROUND: The importance of tapering is increasingly recognised when discontinuing antidepressant medication. However, no previous studies have examined the reporting of antidepressant tapering methods in published studies. AIM: The aim of this study was to assess the completeness of reporting of antidepressant tapering methods in a published systematic review using the Template for Intervention Description and Replication (TIDieR) checklist. METHOD: A secondary analysis was conducted of studies included in a Cochrane systematic review that examined the effectiveness of approaches for discontinuing long-term antidepressant use. The completeness of reporting of antidepressant tapering methods in included studies was independently assessed by two researchers using the 12 items from the TIDieR checklist. RESULTS: Twenty-two studies were included in the analysis. None of the study reports described all checklists items. No study clearly reported what materials had been provided (item 3) or whether tailoring had occurred (item 9). With the exception of providing a name for the intervention or study procedures (item 1), only a minority of studies clearly reported on any of the remaining checklist items. CONCLUSION: The findings highlight a lack of detailed reporting of antidepressant tapering methods in published trials to date. This needs to be addressed as poor reporting could hinder replication and adaptation of existing interventions, as well as the potential for successful translation of effective tapering interventions into clinical practice. Springer International Publishing 2023-06-03 2023 /pmc/articles/PMC10600051/ /pubmed/37269440 http://dx.doi.org/10.1007/s11096-023-01602-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article McGoldrick, Amy Byrne, Helen Cadogan, Cathal An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title | An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title_full | An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title_fullStr | An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title_full_unstemmed | An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title_short | An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist |
title_sort | assessment of the reporting of tapering methods in antidepressant discontinuation trials using the tidier checklist |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600051/ https://www.ncbi.nlm.nih.gov/pubmed/37269440 http://dx.doi.org/10.1007/s11096-023-01602-z |
work_keys_str_mv | AT mcgoldrickamy anassessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist AT byrnehelen anassessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist AT cadogancathal anassessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist AT mcgoldrickamy assessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist AT byrnehelen assessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist AT cadogancathal assessmentofthereportingoftaperingmethodsinantidepressantdiscontinuationtrialsusingthetidierchecklist |